The Effect of CYP3A Genetic Polymorphism on the Pharmacokinetics of Phosphodiesterase type5 Inhibitors in Male Subjects

Clinical trial NCT00767598 · COMPLETED

Trial details

NCT number: NCT00767598
Sponsor: Inje University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics of Three PDE5Is Healthy Subjects Genetic Polymorphic CYP3A5

Start date: 2007-12-01
Primary completion: 2007-12-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.